The Conestoga Small Cap Composite surged 1.67% (net ... Conestoga Capital Advisors emphasized stocks such as West Pharmaceutical Services, Inc. (NYSE:WST). West Pharmaceutical Services, Inc ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what to look for. West Pharmaceutical Services beat analysts’ revenue ...

Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

West Pharmaceutical Services (WST) stock was upgraded to Buy at Deutsche Bank due to an attractive entry point post-selloff. Read more here.

The Conestoga Small Cap Composite surged 1.67% (net ... In its fourth quarter 2024 investor letter, Conestoga Capital Advisors emphasized stocks such as West Pharmaceutical Services, Inc. (NYSE:WST).

KeyBanc analyst Paul Knight maintained a Buy rating on West Pharmaceutical Services (WST – Research Report) today and set a price target of ...

West Pharmaceutical Services has a 52 week low of $265.00 and a 52 week high of $409.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.23 and a current ratio of 3.00. West ...

In another article we discussed West Pharmaceutical Services, Inc. (NYSE:WST) and shared ClearBridge Mid Cap Growth Strategy’s views on the company. In addition, please check out our hedge fund ...

West Pharmaceutical Services, Inc. has a 12 month low of $265.00 and a 12 month high of $409.72. The firm has a market cap of $23.48 billion, a price-to-earnings ratio of 48.11, a P/E/G ratio of ...